A.B. 279
Assembly Bill No. 279–Assemblymen Leslie, Gibbons, Giunchigliani, Goldwater, Parks, Anderson, Buckley, Carpenter, Chowning, Collins, Freeman, Humke, Koivisto, Manendo, McClain, Neighbors, Oceguera, Parnell, Price, Smith and Williams
March 6, 2001
____________
Referred to Committee on Commerce and Labor
SUMMARY—Provides for availability of industrial insurance benefits to providers of health care for exposure to certain contagious diseases. (BDR 53‑123)
FISCAL NOTE: Effect on Local Government: Yes.
~
EXPLANATION
– Matter in bolded italics is new; matter
between brackets [omitted material] is material to be omitted.
Green numbers along left margin indicate location on the printed bill (e.g., 5-15 indicates page 5, line 15).
AN ACT relating to occupational disease; providing for the availability of industrial insurance benefits to providers of health care for exposure to certain contagious diseases; and providing other matters properly relating thereto.
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1-1 Section 1. Chapter 617 of NRS is hereby amended by adding thereto
1-2 the provisions set forth as sections 2 and 3 of this act.
1-3 Sec. 2. 1. Notwithstanding any other provision of this chapter and
1-4 except as otherwise provided in this section, if an employee has a
1-5 contagious, blood-borne disease including, without limitation, acquired
1-6 immune deficiency syndrome, hepatitis B or hepatitis C, that results in a
1-7 temporary or permanent disability or death, the disease is an
1-8 occupational disease and compensable as such under the provisions of
1-9 this chapter if:
1-10 (a) The employee has been employed in this state as a provider of
1-11 health care; and
1-12 (b) It is demonstrated that:
1-13 (1) He was exposed, during the course of that employment, to blood
1-14 or bodily fluids of a potentially infectious nature; and
1-15 (2) The exposure is reasonably associated with the contagious
1-16 disease.
1-17 2. Such an employee and his dependents are excluded from the
1-18 benefits of this section if:
2-1 (a) The employee was diagnosed with the contagious disease before
2-2 the commencement of the employment; or
2-3 (b) It is proven by clear and convincing evidence that the contagious
2-4 disease did not arise out of and in the course of the employment.
2-5 3. The provisions of this section apply to a provider of health care
2-6 who is diagnosed with a contagious, blood-borne disease after the
2-7 termination of the employment if the diagnosis is made within 1 year
2-8 after the last day of the employment.
2-9 4. Compensation awarded to an employee or his dependents
2-10 pursuant to this section must include the compensation provided in
2-11 chapters 616A to 616D, inclusive, of NRS for the contagious disease and
2-12 any additional diseases or conditions that are associated with or result
2-13 from the disease.
2-14 5. As used in this section, “provider of health care” means a person
2-15 who is licensed, certified or otherwise authorized by the law of this state
2-16 to administer health care in the ordinary course of business or practice
2-17 of a profession.
2-18 Sec. 3. 1. Notwithstanding any other provision of this chapter and
2-19 except as otherwise provided in this section, if an employee is infected
2-20 with antibodies associated with a contagious, blood-borne disease
2-21 including, without limitation, acquired immune deficiency syndrome,
2-22 hepatitis B or hepatitis C, and the infection results in a temporary or
2-23 permanent disability or death, the infection is an occupational disease
2-24 and compensable as such under the provisions of this chapter if:
2-25 (a) The employee has been employed in this state as a provider of
2-26 health care; and
2-27 (b) It is demonstrated that:
2-28 (1) The employee sustained a percutaneous injury from the use of a
2-29 sharp device while administering health care during the course of that
2-30 employment to a patient who has been diagnosed with such a disease;
2-31 (2) The employee reported the injury to his employer in compliance
2-32 with reporting requirements adopted by the employer; and
2-33 (3) A blood test administered to the employee within 12 months
2-34 after the date of the injury reveals that the employee has the antibodies
2-35 associated with the contagious disease.
2-36 2. Such an employee and his dependents are excluded from the
2-37 benefits of this section if:
2-38 (a) The employee tested positive for the presence of the antibodies
2-39 before the commencement of the employment; or
2-40 (b) It is proven by clear and convincing evidence that the infection did
2-41 not arise out of and in the course of the employment.
2-42 3. Compensation awarded to an employee or his dependents
2-43 pursuant to this section must include the compensation provided in
2-44 chapters 616A to 616D, inclusive, of NRS for the infection and any
2-45 additional diseases or conditions that are associated with or result from
2-46 the infection.
2-47 4. As used in this section:
2-48 (a) “Percutaneous injury” means the parenteral introduction of blood
2-49 or another potentially infectious material into the body of a provider of
3-1 health care through his skin during the performance of his official
3-2 duties.
3-3 (b) “Provider of health care” means a person who is licensed, certified
3-4 or otherwise authorized by the law of this state to administer health care
3-5 in the ordinary course of business or practice of a profession.
3-6 (c) “Sharp device” means any instrument used for the withdrawal of
3-7 bodily fluids, the administration of medication or fluids or any other
3-8 procedure that may cause the infliction of a percutaneous injury. The
3-9 term includes, without limitation, a needle, lancet and scalpel.
3-10 H